Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity

Abstract

Background The failure of novel therapies effective in preclinical animal models largely reflects the fact that current models do not really mimic the pathological/therapeutic features of glioblastoma (GBM), in which the most effective temozolomide chemoradiotherapy (RT/TMZ) regimen can only slightly extend survival. How to improve RT/TMZ efficacy remains a major challenge in clinic. Methods Syngeneic G422TN-GBM model mice were subject to RT/TMZ, surgery, piperlongumine (PL), αPD1, glutathione. Metabolomics or transcriptomics data from G422TN-GBM and human GBM were used for gene enrichment analysis and estimation of ROS generation/scavenging balance, oxidative stress damage, inflammation and immune cell infiltration. Overall survival, bioluminescent imaging, immunohistochemistry, and immunofluorescence staining were used to examine therapeutic efficacy and mechanisms of action. Results Here we identified that glutathione metabolism was most significantly altered in metabolomics analysis upon RT/TMZ therapies in a truly refractory and reliable mouse triple-negative GBM (G422TN) preclinical model. Consistently, ROS generators/scavengers were highly dysregulated in both G422TN-tumor and human GBM. The ROS-inducer PL synergized surgery/TMZ, surgery/RT/TMZ or RT/TMZ to achieve long-term survival (LTS) in G422TN-mice, but only one LTS-mouse from RT/TMZ/PL therapy passed the rechallenging phase (immune cure). Furthermore, the immunotherapy of RT/TMZ/PL plus anti-PD-1 antibody (αPD1) doubled LTS (50%) and immune-cured (25%) mice. Glutathione completely abolished PL-synergistic effects. Mechanistically, ROS reduction was associated with RT/TMZ-resistance. PL restored ROS level (mainly via reversing Duox2/Gpx2), activated oxidative stress/inflammation/immune responses signature genes, reduced cancer cell proliferation/invasion, increased apoptosis and CD3+/CD4+/CD8+ T-lymphocytes in G422TN-tumor on the basis of RT/TMZ regimen. Conclusion Our findings demonstrate that PL reverses RT/TMZ-reduced ROS and synergistically resets tumor microenvironment to cure GBM. RT/TMZ/PL or RT/TMZ/PL/αPD1 exacts effective immune cure in refractory GBM, deserving a priority for clinical trials.

Cordyceps militaris Extract and Cordycepin Alleviate Oxidative Stress, Modulate Gut Microbiota and Ameliorate Intestinal Damage in LPS-Induced Piglets

“…Analysis of the DEGs through the KEGG pathway database revealed that they were primarily enriched in pathways including "complement and coagulation cascades", the "PI3K-Akt pathway signaling pathway", "Staphylococcus aureus infection", "Glutathione metabolism" and "Primary bile acid biosynthesis". Most of these pathways are associated with the immune system and infectious diseases [60][61][62][63]. This study showed that LPS upregulated the expression of differentially expressed genes involved in complement and coagulation cascade reactions, including CFD, F2RL2, CFB, C4BPA, F7, C4BPB, CFH, C3 and PROS1, and downregulated KLKB1 levels.…”

Influence of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) on Glycolytic Metabolism of Canine Glioma: A Potential Improvement in Cancer Metabolism

“…TMZ (Sigma, St Louis, MO, USA) and EVO (TH-302; Threshold Pharmaceuticals, South San Francisco, CA, USA) were prepared for use in treating the cell lines or mice by dissolving and diluting them in either 0.05% dimethyl sulfoxide or PBS, in accordance with the manufacturer's protocols and previous reports [14,15,19].…”

Using Information from Public Databases to Critically Evaluate Studies Linking the Antioxidant Enzyme Selenium-Dependent Glutathione Peroxidase 2 (GPX2) to Cancer

“…We did come across a curious case where a mouse glioma cell line cultured as tumors in mice was evaluated for gene expression by both RT-PCR and FPKM [91]. The FPKM metric implied GPX2 expression amounted to ~0.003% of the total antioxidant enzyme gene profile (0.75/26,000-42,000 total FPKM) across four sets of experimental conditions, with only small variation (range, 0-4 FPKM; note that a positive signal was reported for none of the samples in one set, one of three samples in two sets, and two of three samples in the last set).…”